Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Pearce

Showing results (261-270 of 301) with videos related to

Pageof 31
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 28, 1999
Novel quinolizidine salicylamide influenza fusion inhibitorsK L Yu, E Ruediger, G Luo, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 31, 2013
Neuropathological changes in the substantia nigra in schizophrenia but not depressionM R Williams, K Galvin, B O'Sullivan, et al.
JAMA|September 16, 1992
Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias (POSCH) GroupH Buchwald, J P Matts, L L Fitch, et al.
Acta Neuropathologica Communications|April 27, 2019
Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson's disease with cognitive declineAlan King Lun Liu, Tsz Wing Chau, Ernest Junwei Lim, et al.
Journal of Virology|May 4, 2012
Seasonal trivalent inactivated influenza vaccine protects against 1918 Spanish influenza virus infection in ferretsMelissa B Pearce, Jessica A Belser, Kortney M Gustin, et al.
The New England Journal of Medicine|October 4, 1990
Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)H Buchwald, R L Varco, J P Matts, et al.
Virology|July 25, 2009
RIG-I activation inhibits ebolavirus replicationChristina F Spiropoulou, Priya Ranjan, Melissa B Pearce, et al.
Plos One|October 27, 2010
Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 virusesGraeme E Price, Mark R Soboleski, Chia-Yun Lo, et al.
Controlled Clinical Trials|April 11, 1991
Program on the Surgical Control of the Hyperlipidemias (POSCH): patient entry characteristics. The POSCH GroupJ P Matts, H Buchwald, L L Fitch, et al.
Journal of Clinical Epidemiology|March 1, 1995
Subgroup analyses of the major clinical endpoints in the Program on the Surgical Control of the Hyperlipidemias (POSCH): overall mortality, atherosclerotic coronary heart disease (ACHD) mortality, and ACHD mortality or myocardial infarctionJ P Matts, H Buchwald, L L Fitch, et al.
Pageof 31

Showing results (261-270 of 301) with videos related to

Sort By:
Pageof 31
Bioorganic & Medicinal Chemistry Letters|August 28, 1999
Novel quinolizidine salicylamide influenza fusion inhibitorsK L Yu, E Ruediger, G Luo, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 31, 2013
Neuropathological changes in the substantia nigra in schizophrenia but not depressionM R Williams, K Galvin, B O'Sullivan, et al.
JAMA|September 16, 1992
Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias (POSCH) GroupH Buchwald, J P Matts, L L Fitch, et al.
Acta Neuropathologica Communications|April 27, 2019
Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson's disease with cognitive declineAlan King Lun Liu, Tsz Wing Chau, Ernest Junwei Lim, et al.
Journal of Virology|May 4, 2012
Seasonal trivalent inactivated influenza vaccine protects against 1918 Spanish influenza virus infection in ferretsMelissa B Pearce, Jessica A Belser, Kortney M Gustin, et al.
The New England Journal of Medicine|October 4, 1990
Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)H Buchwald, R L Varco, J P Matts, et al.
Virology|July 25, 2009
RIG-I activation inhibits ebolavirus replicationChristina F Spiropoulou, Priya Ranjan, Melissa B Pearce, et al.
Plos One|October 27, 2010
Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 virusesGraeme E Price, Mark R Soboleski, Chia-Yun Lo, et al.
Controlled Clinical Trials|April 11, 1991
Program on the Surgical Control of the Hyperlipidemias (POSCH): patient entry characteristics. The POSCH GroupJ P Matts, H Buchwald, L L Fitch, et al.
Journal of Clinical Epidemiology|March 1, 1995
Subgroup analyses of the major clinical endpoints in the Program on the Surgical Control of the Hyperlipidemias (POSCH): overall mortality, atherosclerotic coronary heart disease (ACHD) mortality, and ACHD mortality or myocardial infarctionJ P Matts, H Buchwald, L L Fitch, et al.
Pageof 31